Minimally invasive treatment of Dupuytren´s contractures with Clostridium histolyticum collagenase
All patients treated for Dupuytens disease at the Regional Hospital in Horsens from 2013 to 2016 with Clostridium histolyticum collagenase with a minimum of one year follow-up were reassessed in order to determine long-term outcomes.
Original Article 13/02
